The Phentolamine Mesylate market is poised for steady growth through 2032, leveraging its critical role in pharmaceutical applications. This alpha-adrenergic blocker, recognized for its vasodilatory effects, maintains consistent demand across therapeutic areas including hypertension management and diagnostic applications. While developed markets show maturity, emerging regions present new...
